Medicalgorithmics Summarizes Third Quarter of 2023 and the First Quarter of Execution of its New Business Strategy
Medicalgorithmics, a MedTech company listed in the sWIG80 index, continues to successfully transform its business model in line with the objectives defined in its new development strategy adapted in June 2023. The company has secured several new, significant business partners, including three global leaders in modern cardiac diagnostics, with the goal of becoming their main provider of diagnostic software based on artificial intelligence algorithms.